Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jirkovská, A."'
Autor:
Michal Dubský, Jitka Husáková, Robert Bem, Alexandra Jirkovská, Andrea Němcová, Vladimíra Fejfarová, Karol Sutoris, Michal Kahle, Edward B. Jude
Publikováno v:
Frontiers in endocrinology. 13
Chronic limb-threatening ischemia (CLTI) is a new term used for the end stage of peripheral arterial disease instead of the older term “critical limb ischemia”. Management of CLTI has been recently summarized in a guideline document, ‘Global Va
Autor:
Eliška Vrátná, Jitka Husáková, Radka Jarošíková, Michal Dubský, Veronika Wosková, Robert Bém, Alexandra Jirkovská, Kateřina Králová, Bára Pyšková, Věra Lánská, Vladimíra Fejfarová
Publikováno v:
Frontiers in endocrinology. 13
ObjectivesDiabetic foot syndrome (DFS) is a serious late diabetic complication characterised by limited joint mobility and other biomechanical and muscle abnormalities.AimTo evaluate the effect of an interventional exercise programme on anthropometri
Autor:
Vladimíra Fejfarová, Jiří Matuška, Edward Jude, Pavlína Piťhová, Milan Flekač, Karel Roztočil, Veronika Wosková, Michal Dubský, Alexandra Jirkovská, Robert Bém, Jitka Husáková, Věra Lánská
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundAll diagnostic procedures of peripheral arterial disease (PAD) in diabetic foot (DF) are complicated due to diabetes mellitus and its late complications.The aim of our study is to enhance diagnosis of PAD using a novel transcutaneous oximet
Autor:
Edward B. Jude, Jelena Skibova, Andrea Němcová, Vladimíra Fejfarová, Jitka Hazdrová, Jaroslav Chlupac, Alexandra Jirkovská, Michal Dubský, Karol Sutoris, Robert Bém
Publikováno v:
Diabetic Medicine. 36:1133-1140
AIM To assess the impact of autologous cell therapy on critical limb ischaemia in people with diabetes and diabetic kidney disease. METHODS A total of 59 people with diabetes (type 1 or type 2) and critical limb ischaemia, persisting after standard r
Autor:
Robert Bém, Vladimíra Fejfarová, Andrea Nemcova, Jitka Husáková, Karol Sutoris, Alexandra Jirkovská, Michal Dubsky
Publikováno v:
Diabetes. 69
Background: Autologous cell-therapy (ACT) is a new treatment method for patients with diabetes and no-option chronic limb-threatening ischemia (NO-CLTI). We aimed to assess the impact of ACT on CLTI in comparison with standard treatment (ST) in a ran
Autor:
Alexandra Jirkovská, Andrea Nemcova, Jitka Husáková, Vladimíra Fejfarová, Michal Dubsky, Robert Bém
Publikováno v:
Diabetes. 69
Background: Autologous cell therapy (ACT) is the last option for patients with no-option chronic limb-threatening ischemia (NO-CLTI) and severe pain. The aim of our study was to assess the impact of ACT on a patient’s quality of life, chronic pain
Autor:
Edward B. Jude, Andrea Nemcova, Michal Dubský, Alexandra Jirkovská, Vladimíra Fejfarová, Robert Bém
Publikováno v:
Diabetes Research and Clinical Practice. 126:263-271
In this review we report on the state of cell therapy of critical limb ischemia (CLI) with respect to differences between diabetic and non-diabetic patients mainly from the clinical point of view. CLI is the most severe form of peripheral arterial di
Autor:
Bedřich Sixta, Eliška Vrátná, Věra Lánská, Karol Sutoris, Michal Dubský, Vladimíra Fejfarová, Veronika Wosková, Alexandra Jirkovská, Robert Bém, David G. Armstrong, Filip Thieme, Andrea Němcová, Jaroslav Pavlů, Jitka Hazdrová
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Journal of Diabetes Research
Journal of Diabetes Research
Objective. Off-loading is one of the crucial components of diabetic foot (DF) therapy. However, there remains a paucity of studies on the most suitable off-loading for DF patients under postoperative care. The aim of our study was to evaluate the eff
Autor:
Katherine Ogurtsova, Michal Dubský, Dan Ziegler, Alexandra Jirkovská, Andrea Icks, Gerhard Rümenapf, Stephan Morbach, Burkhard Haastert
Publikováno v:
Diabetes Research and Clinical Practice. 172:108621
Aims Our aim was to comprehensively estimate the incidence of diabetic foot ulcer (DFU) recurrence and corresponding risk factors in two cohorts. Methods Prospective data from patients with active DFU from two diabetes centres in Germany (GER, n = 22
Autor:
V. Urbancic, Alexandra Jirkovská, H. Reike, Kristien Van Acker, Marleen Kars, Luigi Uccioli, Jeff G. van Baal, Didac Mauricio, Edward B. Jude, Gunnel Ragnarson Tennvall, Per Holstein, K. Bakker, Nicolaas C. Schaper, Alberto Piaggesi, Jan Apelqvist, Michael Edmonds, M. Spraul, K. Pickwell, Volkert Siersma
Publikováno v:
Diabetes Care, 38(5), 852-857. American Diabetes Association
DIABETES CARE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
DIABETES CARE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
OBJECTIVE Infection commonly complicates diabetic foot ulcers and is associated with a poor outcome. In a cohort of individuals with an infected diabetic foot ulcer, we aimed to determine independent predictors of lower-extremity amputation and the p